397 related articles for article (PubMed ID: 26784218)
1. Advances and Challenges in Studying Hepatitis B Virus In Vitro.
Witt-Kehati D; Bitton Alaluf M; Shlomai A
Viruses; 2016 Jan; 8(1):. PubMed ID: 26784218
[TBL] [Abstract][Full Text] [Related]
2. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
3. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
[TBL] [Abstract][Full Text] [Related]
4. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus.
Kaneko S; Kakinuma S; Asahina Y; Kamiya A; Miyoshi M; Tsunoda T; Nitta S; Asano Y; Nagata H; Otani S; Kawai-Kitahata F; Murakawa M; Itsui Y; Nakagawa M; Azuma S; Nakauchi H; Nishitsuji H; Ujino S; Shimotohno K; Iwamoto M; Watashi K; Wakita T; Watanabe M
Sci Rep; 2016 Jul; 6():29358. PubMed ID: 27386799
[TBL] [Abstract][Full Text] [Related]
5. Advances in HBV infection and replication systems in vitro.
Xu R; Hu P; Li Y; Tian A; Li J; Zhu C
Virol J; 2021 May; 18(1):105. PubMed ID: 34051803
[TBL] [Abstract][Full Text] [Related]
6. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
Tsukuda S; Watashi K; Iwamoto M; Suzuki R; Aizaki H; Okada M; Sugiyama M; Kojima S; Tanaka Y; Mizokami M; Li J; Tong S; Wakita T
J Biol Chem; 2015 Feb; 290(9):5673-84. PubMed ID: 25550158
[TBL] [Abstract][Full Text] [Related]
9. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture.
Xu G; Gao Z; He W; Ma Y; Feng X; Cai T; Lu F; Liu L; Li W
Virology; 2014 Jan; 448():247-54. PubMed ID: 24314655
[TBL] [Abstract][Full Text] [Related]
10. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
11. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
Yan H; Li W
Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
[TBL] [Abstract][Full Text] [Related]
12. Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection.
Sakurai F; Mitani S; Yamamoto T; Takayama K; Tachibana M; Watashi K; Wakita T; Iijima S; Tanaka Y; Mizuguchi H
Sci Rep; 2017 Apr; 7():45698. PubMed ID: 28374759
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.
Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F
Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847
[TBL] [Abstract][Full Text] [Related]
14. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
16. Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques.
Burwitz BJ; Wettengel JM; Mück-Häusl MA; Ringelhan M; Ko C; Festag MM; Hammond KB; Northrup M; Bimber BN; Jacob T; Reed JS; Norris R; Park B; Moller-Tank S; Esser K; Greene JM; Wu HL; Abdulhaqq S; Webb G; Sutton WF; Klug A; Swanson T; Legasse AW; Vu TQ; Asokan A; Haigwood NL; Protzer U; Sacha JB
Nat Commun; 2017 Dec; 8(1):2146. PubMed ID: 29247188
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.
Ni Y; Urban S
Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.
Nio Y; Akahori Y; Okamura H; Watashi K; Wakita T; Hijikata M
Biochem Biophys Res Commun; 2018 Jun; 501(3):820-825. PubMed ID: 29723527
[TBL] [Abstract][Full Text] [Related]
19. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
